Literature DB >> 1911146

Increased monocyte-dependent suppression of polyclonal activation of B lymphocytes from cystinotic children.

G Pintos-Morell1, G Jean, M Dechaux, P Niaudet.   

Abstract

In infantile cystinosis the amino acid cystine preferentially accumulates in phagocytic cells, polymorphonuclear leucocytes (PMN) and monocytes, rather than in lymphocytes. We previously described functional abnormalities in the oxidative metabolism and locomotion of cystinotic PMN and monocytes. The present study shows an abnormal lymphocyte polyclonal activation as evidenced by a decreased immunoglobulin (Ig) production and generation of Ig-containing cells (ICC) in cultures of peripheral blood mononuclear cells (PBMC) from cystinotic children upon stimulation with pokeweed mitogen and Staphylococcus aureus Cowan I. However, monocyte depletion from cystinotic PBMC fully reconstituted Ig production and ICC generation, indicating: (1) the presence of an increased monocyte-dependent suppression on lymphocyte polyclonal activation, and (2) that the intrinsic ability of cystinotic lymphocytes to respond to polyclonal stimulation was preserved. The increased cystinotic monocyte-dependent suppressive effect was not mediated by prostaglandin E2 (PGE2) since its production by cystinotic PBMC upon polyclonal activation was not different from that of controls. In addition, the sensitivity of cystinotic lymphocytes to the immunosuppressive effect of varying concentrations of exogenous PGE2 was similar to that of controls. Finally, indomethacin and 2-mercaptoethanol, two agents able to scavenge hydroxyl (.OH) radicals, restored Ig production by cystinotic PBMC, suggesting a role for reactive oxygen species in the increased cystinotic monocyte-dependent suppression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911146     DOI: 10.1007/bf00856649

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  30 in total

1.  Characterization of the lysosomal cystine transport system in mouse L-929 fibroblasts.

Authors:  A A Greene; E G Marcusson; G P Morell; J A Schneider
Journal:  J Biol Chem       Date:  1990-06-15       Impact factor: 5.157

2.  Combined report on regular dialysis and transplantation of children in Europe, 1980.

Authors:  M Broyer; R A Donckerwolcke; F P Brunner; H Brynger; C Jacobs; P Kramer; N H Selwood; A J Wing; P H Blake
Journal:  Proc Eur Dial Transplant Assoc       Date:  1981

3.  Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells.

Authors:  P K Peterson; B Sharp; G Gekker; C Brummitt; W F Keane
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

4.  Defective IFN-gamma production in the human neonate. II. Role of increased sensitivity to the suppressive effects of prostaglandin E.

Authors:  N Wakasugi; J L Virelizier; F Arenzana-Seisdedos; B Rothhut; J M Huerta; F Russo-Marie; W Fiers
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

5.  Radioimmunoassay of prostaglandins Falpha, E1 and E2 in human plasma.

Authors:  F Dray; B Charbonnel; J Maclouf
Journal:  Eur J Clin Invest       Date:  1975-07-29       Impact factor: 4.686

6.  Agents which block membrane lipid peroxidation enhance mouse spleen cell immune activities in vitro: relationship to the enhancing activity of 2-mercaptoethanol.

Authors:  J T Hoffeld
Journal:  Eur J Immunol       Date:  1981-05       Impact factor: 5.532

7.  Suppression of human lymphocyte mitogenesis mediated by phagocyte-released reactive oxygen species: comparative activities in normals and in chronic granulomatous disease.

Authors:  D C Zoschke; R P Messner
Journal:  Clin Immunol Immunopathol       Date:  1984-07

8.  Regulation of human B cell activation by prostaglandin E2. Suppression of the generation of immunoglobulin-secreting cells.

Authors:  D F Jelinek; P A Thompson; P E Lipsky
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

9.  In vitro synthesis of prostaglandins and related lipids by populations of human peripheral blood mononuclear cells.

Authors:  M S Kennedy; J D Stobo; M E Goldyne
Journal:  Prostaglandins       Date:  1980-07

10.  Analysis of the defects responsible for the impaired regulation of EBV-induced B cell proliferation by rheumatoid arthritis lymphocytes. II. Role of monocytes and the increased sensitivity of rheumatoid arthritis lymphocytes to prostaglandin E.

Authors:  F Hasler; H G Bluestein; N J Zvaifler; L B Epstein
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.